All Industries

Top Biotech Companies

3,960 Biotech companies, sorted by total funding raised.

nChroma Bio

Genetic medicines company developing targeted in vivo delivery and engineered epigenetic silencer...

Boston, United States51–200Biotech, Genomics
Corporate Round·$335.0M·Dec 2024
ProFound Therapeutics

Biotech company pioneering discovery of an expanded human proteome to develop new medicines for c...

United States11–50Biotech
Series B·$333.0M·May 2026
Bolt Threads

Biotech company developing sustainable biomaterials including mycelium leather and silk proteins ...

Emeryville11–50Biotech, Climate Tech
Series E·$332.3M·Nov 2024
Compass TherapeuticsIPO

Clinical-stage biotech developing novel antibody-based cancer therapies targeting the tumor micro...

Cambridge, United States11–50Biotech, Healthcare
Venture Round·$332.0M·Aug 2025
TruepillAcquired

API-connected healthcare infrastructure.

San Mateo, United States1001–5000Digital Health, Healthcare
Series D·$328.0M·Aug 2023
Varda

In-space pharmaceutical manufacturing company that designs, builds, and flies spacecraft to proce...

El Segundo, United States51–200Biotech, Manufacturing
Series C·$328.0M·Jul 2025
CryoPortIPO

World's largest manufacturer of cryogenic storage systems supporting clinical trials and commerci...

Nashville, United States501–1000Biotech, Healthcare
Series C·$326.0M·Feb 2021
Obsidian Therapeutics

Clinical-stage biotech pioneering engineered cell and gene therapies using its proprietary cytoDR...

Cambridge, United States51–200Biotech
Series C·$325.0M·Apr 2024
Synchron

Restore lives by deciphering the neural code of the brain Biotech Healthcare Hardware

New York, United States51–200Biotech, Hardware
Series D·$325.0M·Nov 2025
Eat Just

Alternative protein company making plant-based eggs and cultivated meat from animal cells

Alameda, United States201–500Biotech, Food Tech
Venture Round·$321.7M·Sep 2023
ADARX Pharmaceuticals

Clinical-stage biotechnology company developing next-generation RNA therapeutics to treat a broad...

United StatesBiotech, Healthcare
Series C·$321.0M·Aug 2023
Solve Therapeutics

Solve Therapeutics is a biopharmaceutical company that develops next-gen antibody-drug conjugates...

Belmont, United States11–50Life Sciences, Biotech
Series B·$321.0M·Nov 2025
Cymabay TherapeuticsAcquired

Clinical-stage biopharmaceutical company developing therapies for liver and other chronic disease...

Newark, United States11–50Biotech, Healthcare
Venture Round·$320.7M·Jan 2023
Leyden Labs

Leyden Labs is a clinical-stage biotech developing intranasal antibody sprays that block respirat...

Leiden, Netherlands11–50Biotech, Healthcare
Venture Round·$320.0M·Jun 2026
Corvus PharmaceuticalsIPO

Clinical-stage biopharmaceutical company focused on developing ITK inhibitor medicines for cancer...

Burlingame, United States11–50Biotech, Healthcare
Corporate Round·$319.1M·Jan 2026
Haihe Pharmaceutical

Chinese biotechnology company focused on discovery, development, and commercialization of cancer ...

Shanghai, China201–500Biotech, Healthcare
Series B·$318.0M·Jul 2020
Noema Pharma

Clinical-stage biotech developing oral small molecule therapeutics for debilitating CNS disorders...

Basel, Switzerland11–50Biotech
Extension Round·$318.0M·Dec 2024
Zenas BioPharmaIPO

Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...

Boston, United States51–200Biotech, Healthcare
Series C·$318.0M·May 2024
CG OncologyIPO

CG Oncology is a late-stage clinical biopharmaceutical company developing and commercializing bla...

Irvine, United States51–200Biotech, Healthcare
Series F·$317.6M·Aug 2023
Ohalo Genetics

Gene editing for plant breeding to create new crop varieties.

South San Francisco, United States51–200AgriTech, Gene Editing
Series C·$317.3M·Feb 2025
eGenesis

Biotech engineering genetically modified pig organs for human xenotransplantation using CRISPR te...

Cambridge, United States51–200Biotech, Healthcare
Series D·$316.0M·Sep 2024
Neurelis

Neurelis is a neuroscience-focused pharmaceutical company developing treatments for neurological ...

San Diego, United States51–200Biotech, Healthcare
Series B·$314.0M·Jun 2023
Bicara TherapeuticsIPO

Clinical-stage biopharma developing dual-action biologics that combine targeted therapy and immun...

Cambridge, United States51–200Biotech, Healthcare
Series C·$313.0M·Dec 2023
LianBioClosed

Biotechnology company developing and commercializing innovative therapies in China and major Asia...

Shanghai, China51–200Biotech, Healthcare
Growth Equity·$313.0M·Oct 2020
Arcutis BiotherapeuticsIPO

Clinical-stage biopharmaceutical company advancing topical treatments for immune-mediated skin di...

Westlake Village, United States201–500Biotech, Healthcare
Growth Equity·$310.5M·Feb 2024